ADAM8 and its single nucleotide polymorphism 2662 T/G are associated with advanced atherosclerosis and fatal myocardial infarction: Tampere vascular study
暂无分享,去创建一个
T. Lehtimäki | M. Perola | M. Kähönen | R. Laaksonen | J. Hernesniemi | J. Soini | N. Oksala | M. Pelto-huikko | A. Huovila | N. Airla | P. Karhunen | J. Salenius | S. Nikkari | E. Ilveskoski | J. Mikkelsson | R. Zeitlin | O. Järvinen | M. Levula | L. Kytömäki | O. Jaakkola | J. Parkkinen | Niku Airla | M. Kähönen | Mari Levula | Leena Kytömäki | Niku Airla
[1] Niku Oksala,et al. ADAM-9, ADAM-15, and ADAM-17 are upregulated in macrophages in advanced human atherosclerotic plaques in aorta and carotid and femoral arteries—Tampere vascular study , 2009, Annals of medicine.
[2] F. Sánchez‐Madrid,et al. Expression and Regulation of the Metalloproteinase ADAM-8 during Human Neutrophil Pathophysiological Activation and Its Catalytic Activity on L-Selectin Shedding1 , 2007, The Journal of Immunology.
[3] D. Sheppard,et al. α9β1: A Novel Osteoclast Integrin That Regulates Osteoclast Formation and Function , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] P. Saftig,et al. Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion. , 2006, Pharmacology & therapeutics.
[5] E. Miyazaki,et al. Role of ADAM8 in experimental asthma. , 2006, Immunology letters.
[6] M. Pelto-huikko,et al. Shedding light on ADAM metalloproteinases. , 2005, Trends in biochemical sciences.
[7] Nikolaos M. Nikolaidis,et al. Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma. , 2004, American Journal of Respiratory Cell and Molecular Biology.
[8] C. Misquitta,et al. The role of 3′-untranslated region (3′-UTR) mediated mRNA stability in cardiovascular pathophysiology , 2001, Molecular and Cellular Biochemistry.
[9] S. Ye,et al. Microarray analysis of peroxisome proliferator-activated receptor-gamma induced changes in gene expression in macrophages. , 2003, Biochemical and biophysical research communications.
[10] E. Fleck,et al. Regulation of the Growth Arrest and DNA Damage-Inducible Gene 45 (GADD45) by Peroxisome Proliferator-Activated Receptor &ggr; in Vascular Smooth Muscle Cells , 2003, Circulation research.
[11] E. Fleck,et al. Peroxisome proliferator-activated receptor γ inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells , 2003 .
[12] E. Fleck,et al. Peroxisome proliferator-activated receptor gamma inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells. , 2003, Molecular endocrinology.
[13] H. Jockusch,et al. The Metalloprotease Disintegrin ADAM8 , 2002, The Journal of Biological Chemistry.
[14] K. Matsuura,et al. CD156 Transgenic Mice , 2002, Pathobiology.
[15] P. Slocombe,et al. The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs , 2002, FEBS letters.
[16] K. Matsuura,et al. CD156 transgenic mice. Different responses between inflammatory types. , 2002, Pathobiology : journal of immunopathology, molecular and cellular biology.
[17] G. Roodman,et al. ADAM8: A Novel Osteoclast Stimulating Factor , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] M. Jaye,et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. , 2000, Nature medicine.
[19] H. Jockusch,et al. Tumor Necrosis Factor α Induces a Metalloprotease-Disintegrin, ADAM8 (CD 156): Implications for Neuron–Glia Interactions during Neurodegeneration , 2000, The Journal of Neuroscience.
[20] J. Takagi,et al. Tissue Transglutaminase, Coagulation Factor XIII, and the Pro-polypeptide of von Willebrand Factor Are All Ligands for the Integrins α9β1 and α4β1 * , 2000, The Journal of Biological Chemistry.
[21] Aldons J. Lusis,et al. Atherosclerosis : Vascular biology , 2000 .
[22] J. Takagi,et al. Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins alpha 9beta 1 and alpha 4beta 1. , 2000, The Journal of biological chemistry.
[23] T. Lehtimäki,et al. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study. , 1999, Circulation.
[24] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[25] K. Matsuura,et al. ADAM family proteins in the immune system. , 1999, Immunology today.
[26] A. Penttilä,et al. Post-mortem cast angiography in the diagnostics of graft complications in patients with fatal outcome following coronary artery bypass grafting (CABG) , 1999, International Journal of Legal Medicine.
[27] C. McCollum,et al. Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries , 1998, Virchows Archiv.
[28] P. Libby,et al. Macrophages in Human Atheroma Contain PPARγ: Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Expression and Reduction of MMP-9 Activity through PPARγ Activation in Mononuclear Phagocytes in Vitro , 1998 .
[29] G. Struhl,et al. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb , 1998, Nature.
[30] P. Libby,et al. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. , 1998, The American journal of pathology.
[31] B. Seed,et al. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. , 1998, Nature.
[32] S. Yamamoto,et al. CD156 (human ADAM8): expression, primary amino acid sequence, and gene location. , 1997, Genomics.
[33] R. Ross,et al. Expression of a disintegrin‐like protein in cultured human vascular cells and in vivo , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] W D Wagner,et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[35] S. Devries,et al. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. , 1994, The American journal of pathology.
[36] P. Libby,et al. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[37] M. Key,et al. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[38] S. Yamamoto,et al. Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. , 1990, International immunology.
[39] A. Penttilä,et al. Validity of post-mortem alcohol reports. , 1990, Alcohol and alcoholism.
[40] E. Berg,et al. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. , 1989, Science.
[41] R. Cotran,et al. Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. , 1985, The American journal of pathology.